![](/img/cover-not-exists.png)
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
Hohaus, S, Funk, L, Martin, S, Schlenk, R F, Abdallah, A, Hahn, U, Egerer, G, Goldschmidt, H, Schneeweiß, A, Fersis, NVolume:
79
Year:
1999
Language:
english
Pages:
8
DOI:
10.1038/sj.bjc.6690239
File:
PDF, 135 KB
english, 1999